A Study Comparing Two Mandibular Advancement Devices in the Treatment of Sleep Apnea

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-20

Study Completion Date

2026-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this randomised, controlled cross-over study is to compare two mandibular repositioning devices (MRA) already on the market in the treatment of mild-to-moderate obstructive sleep apnea.

Patiënt will test the first MRA for 3 months, after a wash out period of 2 weeks they will test the second MRA for 3 months. It will be randomised what type of MRA will be tested first and second.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinial Study of Treatment With Mandibular Advancement Device in Patients With Obstructive Sleep Apnea Across 6 General Hospitals

NCT06837285

Obstructive Sleep Apnea (OSA) Mandibular Advancement Device

COMPLETED

Self-Reported Versus Objective Measured Compliance With Oral Appliance Therapy for Obstructive Sleep Apnea Hypopnea Syndrome

NCT01284881

OSAHS

COMPLETED

PROMAD: Predicting Therapeutic Outcome of Mandibular Advancement Device Treatment in Obstructive Sleep Apnea

NCT01532050

Obstructive Sleep Apnea Syndrome

COMPLETED PHASE4

Validation of Functional Imaging as Predictive Tool for Outcome of Mandibular Replacement Appliance Therapy in Obstructive Sleep Apnea Hypopnea Syndrome Patients

NCT01524510

Obstructive Sleep Apnea Syndrome

UNKNOWN PHASE4

Effects From a Mandibular Repositioning Appliance in Patients With Obstructive Sleep Apnea and Snoring

NCT00477009

Sleep Apnea Syndromes Snoring Disorders of Excessive Somnolence

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A mandibular repositioning appliance (MRA) is the primary treatment option for patients with mild to moderate obstructive sleep apnea (OSA), as well as for those with severe OSA who are intolerant to continuous positive airway pressure (CPAP) therapy or for whom surgical interventions are not viable. MRAs function by advancing the mandible, thereby increasing the volume of the upper airway and reducing its tendency to collapse during sleep. Various types of MRAs are available, and multiple classification systems can be employed to distinguish between these different types.

Mandibular repositioning appliances (MRAs) can be either custom-made or universal. Custom-made devices, which are typically more expensive, are fabricated in a dental laboratory using dental impressions. In contrast, prefabricated devices, often thermoplastic MRAs, are generally less costly and readily available over the counter.

Mandibular repositioning appliances (MRAs) can be classified as non-titratable, also known as monoblock devices, which have a fixed position, or titratable devices, which allow for gradual adjustment of the mandibular position until the desired therapeutic effect is achieved. Current guidelines recommend the use of titratable MRAs.

Titratable mandibular repositioning appliances (MRAs) can be further categorized into two types: midline traction devices, where the upper and lower components are connected at the front of the device, and bilateral thrust devices, where the upper and lower components are linked in the lateral or (pre-)molar regions.

Within the latter category, various designs exist, including devices that are adjustable on both sides using Hyrax screws and 3D-printed devices equipped with a series of lower components that allow for adjustments in mandibular position.

An example of an MRA adjustable with Hyrax screws is the SomnoDent® device (SomnoMed, Denton, Texas, USA). An example of a device utilizing a series of lower components for titration is the OrthoApnea appliance (ORTHOAPNEA S.L., Málaga, Spain), which features a specific attachment mechanism.

Although studies have already been published comparing different types of "bilateral thrust" devices, no studies to date have directly compared the categories mentioned above. The hypothesis of the investigators is that both appliances have similar effectiveness in the treatment of mild-to-moderate obstructive sleep apnea.

Primary objective:

Improvement of AHI, measured by polygraphy before treatment and after treatment with each MRA.

Secondary objective;

* Peripheral oxygen saturation, measured by polygraphy before treatment and after treatment with each MRA

* Average saturation
* Lowest saturation
* Oxygen desaturation index \>3% (events/h)
* Total duration with saturation \< 90%
* Epworth Sleepiness Scale, taken before treatment and after treatment with each MRA
* Patient experience questionnaire, taken before treatment and after treatment with each MRA
* Patient final choice of preferred MRA

Endpoints:

The investigators assess the objective improvement in OSA by comparing polygraphy results taken before and after treatment with each MRA. To evaluate the subjective effects of the MRA, the investigators compare the scores from the Epworth Sleepiness Scale. The participants subjective experience with each MRA type is measured using a patient experience questionnaire, along with noting the final preference for device type of the participants.

Study design:

* Randomized, controlled cross-over study
* Study population: Patients referred to the Department of Oral and Maxillofacial Surgery at ZOL Genk for Mandibular Repositioning Appliance (MRA) therapy, aged 18 years or older diagnosed with an Apnea-Hypopnea Index (AHI) between 5 and 30 events per hour.

Inclusion criteria:

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

* Provide signed and dated informed consent
* Males or females aged 18 and above
* Apnea-Hypopnea Index (AHI) between 5 and 30 events per hour diagnosed by a polysomnography

Exclusion criteria:

A potential subject who meets any of the following criteria will be excluded from participation in this study:

* Previous surgery on the upper airways
* Prior treatment of OSA (CPAP or MRA)
* Presence of unstable cardiovascular conditions, neurological, mental, or psychiatric disorders
* Insufficient dental or periodontal condition for a mandibular repositioning appliance (MRA)
* Presence of temporomandibular joint dysfunction

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Apnea, Obstructive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

randomised, controlled cross over study comparing two mandibular advancement devices

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Intervention Type OTHER

Patient final choice of preferred MRA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Polygraphy

Polygraphy will be caried out at the patients home to evaluate each MRA after 3 monhts

Intervention Type DIAGNOSTIC_TEST

Questionaire

Epworth Sleepiness Scale

o Johns, Murray W. "A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale." Sleep, vol. 14, no. 6, 1991, pp. 540-545.

Intervention Type OTHER

Questionaire

Patient experience questionnaire

o Ng, E.T., Perez-Garcia, A., en Lagravère-Vich, M.O. "Development and Initial Validation of a Questionnaire to Measure Patient Experience with Oral Appliance Therapy." Journal of Clinical Sleep Medicine, vol. 19, nr. 8, 1 aug. 2023, pp. 1437-1445. doi: 10.5664/jcsm.10562. PMID: 37082817; PMCID: PMC10394373

Intervention Type OTHER

Question

Patient final choice of preferred MRA

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provide signed and dated informed consent
* Males or females aged 18 and above
* Apnea-Hypopnea Index (AHI) between 5 and 30 events per hour diagnosed by a polysomnography

A potential subject who meets any of the following criteria will be excluded from participation in this study:

* Previous surgery on the upper airways
* Prior treatment of OSA (CPAP or MRA)
* Presence of unstable cardiovascular conditions, neurological, mental, or psychiatric disorders
* Insufficient dental or periodontal condition for a mandibular repositioning appliance (MRA)
* Presence of temporomandibular joint dysfunction

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No